“High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept

PURPOSE: Identifying patient characteristics that define a worse disease prognosis or “high tumor burden” (HTB) status is essential for clinical decision-making and treatment selection in metastatic non-small cell lung cancer (mNSCLC). We aimed to define this concept based on the experience of oncol...

Descripción completa

Detalles Bibliográficos
Autores principales: Higuera Gómez, Oliver, Moreno Paul, Amaia, Ortega Granados, Ana Laura, Ros Martínez, Silverio, Pérez Parente, Diego, Ruiz Gracia, Pedro, Sáenz Cuervo-Arango, Lucía, Vilà, Laia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213951/
https://www.ncbi.nlm.nih.gov/pubmed/34163241
http://dx.doi.org/10.2147/CMAR.S302928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213951/
https://www.ncbi.nlm.nih.gov/pubmed/34163241
http://dx.doi.org/10.2147/CMAR.S302928

Ejemplares similares